Skip to main content
Premium Trial:

Request an Annual Quote

Physiome Sciences Appoints DeLisi to Scientific Advisory Board

NEW YORK, Dec 6 - Physiome Sciences said Wednesday it had appointed Charles DeLisi, to its scientific advisory board.

DeLisi, currently director of the All University Program in Bioinformatics at Boston University, is also a member of the Los Alamos National Laboratory and chairman of the board of scientific counselors for the National Center for Biotechnology Information.

  " We are delighted that Dr. DeLisi has joined Physiome's scientific advisory board, and that we have access to his expertise in the bioinformatics and genomic fields," Jeremy Levin, Chairman and CEO of Physiome Sciences, said in a statement.

Physiome Sciences is a privately held company based in Princeton, NJ. It develops software tools, proprietary databases, and web applications for simulating life processes.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.